Offerings - Spark Newswire

1 minute read

Inhibikase Therapeutics Stock Drops After Follow-On Equity Offering Of $45M Issued At 26% Discount

Today, 5:04 AM

Inhibikase Therapeutics Inc (NASDAQ:IKT) has priced an underwritten public offering of 15 million shares at $3/share for gross proceeds of approximately…

IKT

1 minute read

RAPT Therapeutics Raises $125M Via Equity At 6% Discount

By Vandana Singh

Today, 5:04 AM

RAPT Therapeutics Inc (NASDAQ:RAPT) has priced its previously announced underwritten public offering of 3.8 million shares at $33/share. The price represents…

RAPT

1 minute read

Protagonist Therapeutics Secures $115M Via Equity Raise

By Vandana Singh

Today, 5:04 AM

Protagonist Therapeutics Inc (NASDAQ:PTGX) priced its previously announced underwritten public offering of around 3 million common shares to raise gross proceeds…

PTGX

1 minute read

Nouveau Monde Announces Launch Of 7M Share Public Offering Of Common Shares In United States And Canada

By Bill Haddad

Today, 5:04 AM

Nouveau Monde Graphite Inc. (“Nouveau Monde” or the “Company”) (NYSE:NMG, TSXV:NOU) today announced the launch of a proposed underwritten public offering (the “Offering”) of

NMG

1 minute read

Elys Game Technology Files For Mixed Shelf Of Up To $100M

By Benzinga Newsdesk

Today, 5:04 AM

-SEC Filing-SEC Filing

ELYS

1 minute read

Wah Fu Education Group Files For Mixed Shelf Of Up To $25M

By Benzinga Newsdesk

Today, 5:04 AM

-SEC Filing

WAFU

2 minute read

Novavax Files Prospectus Supplement With SEC Which Contemplates Sale Of Up To $500M Of Shares Of Co’s Common Stock From Time To Time In At-The-Market Offerings

By Benzinga Newsdesk

Today, 5:04 AM

On June 15, 2021, Novavax, Inc. (the “Company”), filed a prospectus supplement with the Securities and Exchange Commission which contemplates the sale of up to $500,000,000 of shares of the Company’s

NVAX

1 minute read

Why Uber’s Stock Is Trading Lower Today

By Randy Elias

Today, 5:04 AM

Uber Technologies, Inc. (NYSE: UBER) shares are trading lower after the company filed a prospectus supplement related to the offering of 1.3 million shares by selling stockholders. Uber will not receive any proceeds from the sale of the shares by the selling stockholders.

UBER

6 minute read

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda

By Shanthi Rexaline

Today, 5:04 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14)

ACHL

2 minute read

Protagonist Therapeutics Announces Proposed Public Offering Of $100M Shares Of Common Stock

By Benzinga Newsdesk

Today, 5:04 AM

Protagonist Therapeutics, Inc. (NASDAQ:PTGX), a clinical stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $100,000,000 of shares of its common stock. All

PTGX